product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Recombinant Human Galactose-1-Phosphate Uridylyltransferase
catalog :
MBS143204
quantity :
0.002 mg
price :
140 USD
more info or order :
product information
catalog number :
MBS143204
products type :
Recombinant Protein
products full name :
Recombinant Human Galactose-1-Phosphate Uridylyltransferase
products short name :
Galactose-1-Phosphate Uridylyltransferase
products name syn :
GALT Human; Galactose-1-Phosphate Uridylyltransferase Human Recombinant; Galactose-1-phosphate uridylyltransferase; Gal-1-P uridylyltransferase; UDP-glucose--hexose-1-phosphate uridylyltransferase; GALT
other names :
galactose-1-phosphate uridylyltransferase isoform 1; Galactose-1-phosphate uridylyltransferase; galactose-1-phosphate uridylyltransferase; UDP-glucose--hexose-1-phosphate uridylyltransferase; gal-1-P uridylyltransferase; galactose-1-phosphate uridyl transferase; galactose-1-phosphate uridylyltransferase; UDP-glucose--hexose-1-phosphate uridylyltransferase
products gene name :
GALT
other gene names :
GALT; GALT; Gal-1-P uridylyltransferase
uniprot entry name :
GALT_HUMAN
host :
E Coli
sequence length :
379
purity :
Greater than 85.0% as determined by SDS-PAGE.
form :
The GALT solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH 8.5), 0.2M NaCl and 10% glycerol. Sterile filtered colorless solution.
storage stability :
Store at 4 degree C if entire vial will be used within 2-4 weeks. Store, frozen at -20 degree C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
products categories :
ENZYMES; Enzymes; Transferase
products description :
Description: GALT Human Recombinant produced in E Coli is a single, non-glycosylated polypeptide chain containing 403 amino acids (1-379) and having a molecular mass of 45.9kDa.GALT is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. Introduction: Galactose-1-Phosphate Uridylyltransferase (GALT) catalyzes the 2nd step of the œLeloir pathway of galactose metabolism, specifically the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The deficiency of the GALT enzyme results in typical galactosemia in humans and may be fatal in the newborn stage if lactose is not eliminated from the diet. Galactosemia pathophysiology has not been clearly defined.
ncbi gi num :
22165416
ncbi acc num :
NP_000146.2
ncbi gb acc num :
NM_000155.3
uniprot acc num :
P07902
ncbi mol weight :
31,107 Da
ncbi pathways :
Amino Sugar And Nucleotide Sugar Metabolism Pathway (82979); Amino Sugar And Nucleotide Sugar Metabolism Pathway (350); D-galactose Degradation V (Leloir Pathway) (1108782); Disease Pathway (530764); Galactose Catabolism Pathway (106219); Galactose Degradation, Leloir Pathway, Galactose = Alpha-D-glucose-1P (961175); Galactose Degradation, Leloir Pathway, Galactose = Alpha-D-glucose-1P (966887); Galactose Metabolism Pathway (82931); Galactose Metabolism Pathway (292); Glycogen Storage Diseases Pathway (1127581)
ncbi summary :
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
uniprot summary :
GALT: Defects in GALT are the cause of galactosemia (GALCT). Galactosemia is an inherited disorder of galactose metabolism that causes jaundice, cataracts, and mental retardation. Belongs to the galactose-1-phosphate uridylyltransferase type 1 family. Protein type: Motility/polarity/chemotaxis; Carbohydrate Metabolism - amino sugar and nucleotide sugar; EC 2.7.7.12; Carbohydrate Metabolism - galactose; Transferase. Chromosomal Location of Human Ortholog: 9p13. Cellular Component: Golgi apparatus; cytosol. Molecular Function: zinc ion binding; UDP-glucose:hexose-1-phosphate uridylyltransferase activity. Biological Process: galactose catabolic process; carbohydrate metabolic process; UDP-glucose catabolic process; galactose metabolic process; pathogenesis. Disease: Galactosemia
size1 :
0.002 mg
price1 :
140 USD
size2 :
0.01 mg
price2 :
205
size3 :
0.1 mg
price3 :
1220
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!